CURX NASDAQ
Curanex Pharmaceuticals Inc Common Stock
1W: -0.4%
1M: +3.7%
3M: +1.9%
YTD: -36.0%
1Y: -69.5%
$4.72
-0.25 (-5.03%)
Weekly Expected Move ±13.0%
$3
$4
$5
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
1 relationships1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-08-26
Earliest Filing
2025-08-26
Latest Filing
partner: 1
Counterparties (Filed by CURX)
1 relationshipsCompanies named in CURX's SEC 8-K filings as business counterparties.
Recent 8-K Filings (12)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-04 | Other Events | View | |
| 2026-08-17 | Bylaws Amendment; Exhibits | View | |
| 2026-05-14 | Regulation FD; Exhibits | View | |
| 2026-05-07 | Other Events | View | |
| 2026-04-02 | Regulation FD; Exhibits | View | |
| 2026-03-06 | Material Agreement; Officer/Director Change; Exhibits | Agreement | View |
| 2026-01-05 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-06 | Notice of Delisting or Transfer | View | |
| 2025-09-29 | Unregistered Sales of Equity Securities; Other Events; Financial Statements and Exhibits | View | |
| 2025-09-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-27 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-26 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR